الاثنين، 14 نوفمبر 2011

ScienceDaily: Health & Medicine News

ScienceDaily: Health & Medicine News


Prenatal exposure to environmental pollutants may affect weight and size of newborn

Posted: 13 Nov 2011 11:27 AM PST

A higher exposure to xenoestrogens -- a type of environmental pollutants acting as hormones -- might affect neonatal weight and size in term infants. Researchers have found a correlation between estrogenic burden in women's placenta and a higher neonatal weight at birth.

Tamoxifen resistance -- and how to defeat it

Posted: 13 Nov 2011 11:14 AM PST

In the last three decades, thousands of women with breast cancer have taken the drug tamoxifen, only to discover that the therapy doesn't work, either because their tumors do not respond to the treatment at all, or because they develop resistance to it over time. Now researchers have discovered the molecular basis for tamoxifen resistance and found a potential way to defeat it.

New way to target – and kill – proliferating tumors

Posted: 13 Nov 2011 11:14 AM PST

Researchers have identified a new drug discovery approach enabling the destruction of the most highly proliferative tumors. The discovery points to an effective, alternative method for killing fast-growing cancer cells without causing some of the negative effects of current therapies.

More flexible window into the brain

Posted: 13 Nov 2011 11:14 AM PST

Scientists have developed and tested a new high-resolution, ultra-thin device capable of recording brain activity from the cortical surface without having to use penetrating electrodes. The device could make possible a whole new generation of brain-computer interfaces for treating neurological and psychiatric illness and research.

Signaling pathway linked to inflammatory breast cancer may drive disease metastasis

Posted: 13 Nov 2011 11:14 AM PST

Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may be a primary driver of the rapid metastasis that patients with inflammatory breast cancer experience.

Benefit of novel drug in breast cancer seen in blood within weeks

Posted: 13 Nov 2011 11:14 AM PST

Clinical benefit from use of a novel histone deacetylase inhibitor drug may be determined by examining blood cells days after a patient receives treatment. The drug, entinostat, is the first histone deacetylase inhibitor successfully tested in a randomized, placebo-controlled study in metastatic breast cancer — and is the first to show that clinical outcome can be predicted shortly after administration.

Wearable defibrillator can prevent death in people with arrhythmias, research finds

Posted: 13 Nov 2011 11:13 AM PST

A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to new research.

Intensive diabetes therapy protects Type 1 diabetics' kidneys

Posted: 12 Nov 2011 11:53 AM PST

Scientists looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect Type 1 diabetics' kidney function.

ليست هناك تعليقات:

إرسال تعليق